These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 23656525)
21. Serelaxin in acute heart failure patients with and without atrial fibrillation: a secondary analysis of the RELAX-AHF trial. Filippatos G; Farmakis D; Metra M; Cotter G; Davison BA; Felker GM; Greenberg BH; Hua TA; Pang PS; Ponikowski P; Qian M; Severin TA; Voors AA; Teerlink JR Clin Res Cardiol; 2017 Jun; 106(6):444-456. PubMed ID: 28150186 [TBL] [Abstract][Full Text] [Related]
22. Serelaxin: new investigational treatment in acute heart failure. Said S; Mukherjee D Cardiovasc Hematol Agents Med Chem; 2013 Sep; 11(3):243-8. PubMed ID: 24289727 [TBL] [Abstract][Full Text] [Related]
23. A randomized study of cardiac resynchronization therapy defibrillator versus dual-chamber implantable cardioverter-defibrillator in ischemic cardiomyopathy with narrow QRS: the NARROW-CRT study. Muto C; Solimene F; Gallo P; Nastasi M; La Rosa C; Calvanese R; Iengo R; Canciello M; Sangiuolo R; Diemberger I; Ciardiello C; Tuccillo B Circ Arrhythm Electrophysiol; 2013 Jun; 6(3):538-45. PubMed ID: 23592833 [TBL] [Abstract][Full Text] [Related]
24. Efficacy and safety of serelaxin when added to standard of care in patients with acute heart failure: results from a PROBE study, RELAX-AHF-EU. Maggioni AP; López-Sendón J; Nielsen OW; Hallén J; Aalamian-Mattheis M; Wang Y; Ertl G Eur J Heart Fail; 2019 Mar; 21(3):322-333. PubMed ID: 30604559 [TBL] [Abstract][Full Text] [Related]
25. Relation of QRS Duration to Clinical Benefit of Cardiac Resynchronization Therapy in Mild Heart Failure Patients Without Left Bundle Branch Block: The Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy Substudy. Biton Y; Kutyifa V; Cygankiewicz I; Goldenberg I; Klein H; McNitt S; Polonsky B; Ruwald AC; Ruwald MH; Moss AJ; Zareba W Circ Heart Fail; 2016 Feb; 9(2):e002667. PubMed ID: 26823498 [TBL] [Abstract][Full Text] [Related]
26. Impact of carvedilol and metoprolol on inappropriate implantable cardioverter-defibrillator therapy: the MADIT-CRT trial (Multicenter Automatic Defibrillator Implantation With Cardiac Resynchronization Therapy). Ruwald MH; Abu-Zeitone A; Jons C; Ruwald AC; McNitt S; Kutyifa V; Zareba W; Moss AJ J Am Coll Cardiol; 2013 Oct; 62(15):1343-50. PubMed ID: 23770172 [TBL] [Abstract][Full Text] [Related]
27. Design of the RELAXin in acute heart failure study. Ponikowski P; Metra M; Teerlink JR; Unemori E; Felker GM; Voors AA; Filippatos G; Greenberg B; Teichman SL; Severin T; Mueller-Velten G; Cotter G; Davison BA Am Heart J; 2012 Feb; 163(2):149-55.e1. PubMed ID: 22305830 [TBL] [Abstract][Full Text] [Related]
33. Left ventricular ejection fraction normalization in cardiac resynchronization therapy and risk of ventricular arrhythmias and clinical outcomes: results from the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT) trial. Ruwald MH; Solomon SD; Foster E; Kutyifa V; Ruwald AC; Sherazi S; McNitt S; Jons C; Moss AJ; Zareba W Circulation; 2014 Dec; 130(25):2278-86. PubMed ID: 25301831 [TBL] [Abstract][Full Text] [Related]
34. Relaxin for the Treatment of Acute Decompensated Heart Failure: Pharmacology, Mechanisms of Action, and Clinical Evidence. Ng TM; Goland S; Elkayam U Cardiol Rev; 2016; 24(4):194-204. PubMed ID: 26331289 [TBL] [Abstract][Full Text] [Related]
35. Cardiac resynchronization therapy in congestive heart failure: Ready for prime time? Manolis AS Heart Rhythm; 2004 Sep; 1(3):355-63. PubMed ID: 15851184 [TBL] [Abstract][Full Text] [Related]
36. Multicenter, Randomized, Double-Blinded, Placebo-Controlled Phase II Study of Serelaxin in Japanese Patients With Acute Heart Failure. Sato N; Takahashi W; Hirayama A; Ajioka M; Takahashi N; Okishige K; Wang X; Maki A; Maruyama H; Ebinger U; Yamaguchi M; Pang Y; Matsumoto H; Kawana M Circ J; 2015; 79(6):1237-47. PubMed ID: 25912697 [TBL] [Abstract][Full Text] [Related]
37. Is there still a role for ultrafiltration in the management of acute heart failure? CARRESS and beyond. Ryan J; Meng S Curr Heart Fail Rep; 2013 Sep; 10(3):185-9. PubMed ID: 23728784 [TBL] [Abstract][Full Text] [Related]
38. Temporal Influence of Heart Failure Hospitalizations Prior to Implantable Cardioverter Defibrillator or Cardiac Resynchronization Therapy With Defibrillator on Subsequent Outcome in Mild Heart Failure Patients (from MADIT-CRT). Lee AY; Moss AJ; Ruwald MH; Kutyifa V; McNitt S; Polonsky B; Zareba W; Ruwald AC Am J Cardiol; 2015 May; 115(10):1423-7. PubMed ID: 25817576 [TBL] [Abstract][Full Text] [Related]
39. Right Ventricular Versus Biventricular Pacing for Heart Failure and Atrioventricular Block. Beck H; Curtis AB Curr Heart Fail Rep; 2016 Oct; 13(5):230-236. PubMed ID: 27553893 [TBL] [Abstract][Full Text] [Related]
40. Mortality reduction in relation to implantable cardioverter defibrillator programming in the Multicenter Automatic Defibrillator Implantation Trial-Reduce Inappropriate Therapy (MADIT-RIT). Ruwald AC; Schuger C; Moss AJ; Kutyifa V; Olshansky B; Greenberg H; Cannom DS; Estes NA; Ruwald MH; Huang DT; Klein H; McNitt S; Beck CA; Goldstein R; Brown MW; Kautzner J; Shoda M; Wilber D; Zareba W; Daubert JP Circ Arrhythm Electrophysiol; 2014 Oct; 7(5):785-92. PubMed ID: 25136077 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]